TP53 and medulloblastoma: Together, these results suggest that Ptch;p53 SI-CSC medulloblastoma cells epigenetically reprogram bulk tumor cells upon chronic SMOi exposure by elevating proteasome activity to degrade specific HATs, consequently changing the histone code and gene expression in SMOi-resistant SI-CSC tumors (Fig. 6H).